539 related articles for article (PubMed ID: 28583723)
1. Control of B lymphocyte development and functions by the mTOR signaling pathways.
Iwata TN; Ramírez-Komo JA; Park H; Iritani BM
Cytokine Growth Factor Rev; 2017 Jun; 35():47-62. PubMed ID: 28583723
[TBL] [Abstract][Full Text] [Related]
2. The Role of Mammalian Target of Rapamycin (mTOR) in Insulin Signaling.
Yoon MS
Nutrients; 2017 Oct; 9(11):. PubMed ID: 29077002
[TBL] [Abstract][Full Text] [Related]
3. Targeted Inhibition of Rictor/mTORC2 in Cancer Treatment: A New Era after Rapamycin.
Zou Z; Chen J; Yang J; Bai X
Curr Cancer Drug Targets; 2016; 16(4):288-304. PubMed ID: 26563881
[TBL] [Abstract][Full Text] [Related]
4. RES-529: a PI3K/AKT/mTOR pathway inhibitor that dissociates the mTORC1 and mTORC2 complexes.
Weinberg MA
Anticancer Drugs; 2016 Jul; 27(6):475-87. PubMed ID: 26918392
[TBL] [Abstract][Full Text] [Related]
5. Dynamic modeling of signal transduction by mTOR complexes in cancer.
Dorvash M; Farahmandnia M; Mosaddeghi P; Farahmandnejad M; Saber H; Khorraminejad-Shirazi M; Azadi A; Tavassoly I
J Theor Biol; 2019 Dec; 483():109992. PubMed ID: 31493485
[TBL] [Abstract][Full Text] [Related]
6. Dynamic modelling of the PI3K/MTOR signalling network uncovers biphasic dependence of mTORC1 activity on the mTORC2 subunit SIN1.
Ghomlaghi M; Yang G; Shin SY; James DE; Nguyen LK
PLoS Comput Biol; 2021 Sep; 17(9):e1008513. PubMed ID: 34529665
[TBL] [Abstract][Full Text] [Related]
7. Discrete signaling mechanisms of mTORC1 and mTORC2: Connected yet apart in cellular and molecular aspects.
Jhanwar-Uniyal M; Amin AG; Cooper JB; Das K; Schmidt MH; Murali R
Adv Biol Regul; 2017 May; 64():39-48. PubMed ID: 28189457
[TBL] [Abstract][Full Text] [Related]
8. mTORC1 and mTORC2 regulate skin morphogenesis and epidermal barrier formation.
Ding X; Bloch W; Iden S; Rüegg MA; Hall MN; Leptin M; Partridge L; Eming SA
Nat Commun; 2016 Oct; 7():13226. PubMed ID: 27807348
[TBL] [Abstract][Full Text] [Related]
9. Structural mechanisms of the mTOR pathway.
Linde-Garelli KY; Rogala KB
Curr Opin Struct Biol; 2023 Oct; 82():102663. PubMed ID: 37572585
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic target of rapamycin: integrating growth factor and nutrient signaling in the collecting duct.
Brown AL; Fluitt MB; Ecelbarger CM
Am J Physiol Renal Physiol; 2018 Sep; 315(3):F413-F416. PubMed ID: 29846113
[TBL] [Abstract][Full Text] [Related]
11. Targeting mTOR Signaling in Type 2 Diabetes Mellitus and Diabetes Complications.
Yang L; Zhang Z; Wang D; Jiang Y; Liu Y
Curr Drug Targets; 2022; 23(7):692-710. PubMed ID: 35021971
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic target of rapamycin complex 1 and 2 in human temporal lobe epilepsy.
Talos DM; Jacobs LM; Gourmaud S; Coto CA; Sun H; Lim KC; Lucas TH; Davis KA; Martinez-Lage M; Jensen FE
Ann Neurol; 2018 Feb; 83(2):311-327. PubMed ID: 29331082
[TBL] [Abstract][Full Text] [Related]
13. Using
Frappaolo A; Giansanti MG
Cells; 2023 Nov; 12(22):. PubMed ID: 37998357
[TBL] [Abstract][Full Text] [Related]
14. mTORC1 and mTORC2 play different roles in regulating cardiomyocyte differentiation from embryonic stem cells.
Zheng B; Wang J; Tang L; Shi J; Zhu D
Int J Dev Biol; 2017; 61(1-2):65-72. PubMed ID: 28287249
[TBL] [Abstract][Full Text] [Related]
15. Role of mTORC1 and mTORC2 in Breast Cancer: Therapeutic Targeting of mTOR and Its Partners to Overcome Metastasis and Drug Resistance.
Butt G; Shahwar D; Qureshi MZ; Attar R; Akram M; Birinci Y; Karatoprak GS; Gasparri ML; Farooqi AA
Adv Exp Med Biol; 2019; 1152():283-292. PubMed ID: 31456190
[TBL] [Abstract][Full Text] [Related]
16. The role of mTOR-mediated signals during haemopoiesis and lineage commitment.
Malik N; Sansom OJ; Michie AM
Biochem Soc Trans; 2018 Oct; 46(5):1313-1324. PubMed ID: 30154096
[TBL] [Abstract][Full Text] [Related]
17. Sin1/mTORC2 regulate B cell growth and metabolism by activating mTORC1 and Myc.
Li M; Lazorchak AS; Ouyang X; Zhang H; Liu H; Arojo OA; Yan L; Jin J; Han Y; Qu G; Fu Y; Xu X; Liu X; Zhang W; Yang Z; Ruan C; Wang Q; Liu D; Huang C; Lu L; Jiang S; Li F; Su B
Cell Mol Immunol; 2019 Sep; 16(9):757-769. PubMed ID: 30705387
[TBL] [Abstract][Full Text] [Related]
18. Rapamycin attenuates BAFF-extended proliferation and survival via disruption of mTORC1/2 signaling in normal and neoplastic B-lymphoid cells.
Zeng Q; Qin S; Zhang H; Liu B; Qin J; Wang X; Zhang R; Liu C; Dong X; Zhang S; Huang S; Chen L
J Cell Physiol; 2018 Jan; 233(1):516-529. PubMed ID: 28300280
[TBL] [Abstract][Full Text] [Related]
19. mTOR substrate phosphorylation in growth control.
Battaglioni S; Benjamin D; Wälchli M; Maier T; Hall MN
Cell; 2022 May; 185(11):1814-1836. PubMed ID: 35580586
[TBL] [Abstract][Full Text] [Related]
20. Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells.
Jiang S; Zou Z; Nie P; Wen R; Xiao Y; Tang J
PLoS One; 2015; 10(7):e0132880. PubMed ID: 26176608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
